PH25612A - Steroids including a spiro-ring in position 17, the process for their preparation, their use - Google Patents

Steroids including a spiro-ring in position 17, the process for their preparation, their use

Info

Publication number
PH25612A
PH25612A PH35068A PH35068A PH25612A PH 25612 A PH25612 A PH 25612A PH 35068 A PH35068 A PH 35068A PH 35068 A PH35068 A PH 35068A PH 25612 A PH25612 A PH 25612A
Authority
PH
Philippines
Prior art keywords
spiro
preparation
ring
steroids including
steroids
Prior art date
Application number
PH35068A
Other languages
English (en)
Inventor
Francois Nique
Lucien Nedelec
Daniel Philibert
Martine Moguilewwsky
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of PH25612A publication Critical patent/PH25612A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PH35068A 1986-03-26 1987-03-24 Steroids including a spiro-ring in position 17, the process for their preparation, their use PH25612A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8604355A FR2596395B1 (fr) 1986-03-26 1986-03-26 Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant

Publications (1)

Publication Number Publication Date
PH25612A true PH25612A (en) 1991-08-08

Family

ID=9333576

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35068A PH25612A (en) 1986-03-26 1987-03-24 Steroids including a spiro-ring in position 17, the process for their preparation, their use

Country Status (27)

Country Link
US (1) US4900725A (ja)
EP (1) EP0262188B1 (ja)
JP (2) JP2684180B2 (ja)
KR (1) KR880701244A (ja)
CN (1) CN1021445C (ja)
AU (1) AU604692B2 (ja)
CA (1) CA1299169C (ja)
DK (1) DK174211B1 (ja)
ES (1) ES2004268A6 (ja)
FI (1) FI87078C (ja)
FR (1) FR2596395B1 (ja)
GR (1) GR870471B (ja)
HU (1) HU198509B (ja)
IE (1) IE60143B1 (ja)
IL (1) IL82004A0 (ja)
MA (1) MA20918A1 (ja)
MX (1) MX5712A (ja)
NZ (1) NZ219776A (ja)
OA (1) OA08505A (ja)
PH (1) PH25612A (ja)
PT (1) PT84554B (ja)
SU (1) SU1715205A3 (ja)
TN (1) TNSN87042A1 (ja)
TR (1) TR23117A (ja)
WO (1) WO1987005908A1 (ja)
YU (1) YU53387A (ja)
ZA (1) ZA872130B (ja)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306846A3 (de) * 1987-09-11 1990-05-02 Dr. Karl Thomae GmbH Neue synergistische Kombination bestehend aus einem Phosphodiesterase-Hemmer und einem Thromboxan-A2-Antagonisten und deren Verwendung bzw. Herstellung
FR2620707B1 (fr) * 1987-09-18 1989-12-08 Roussel Uclaf Nouveaux steroides comportant un cycle spirannique a 3, 4 ou 6 chainons en position 17, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
DE3921059A1 (de) * 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
FR2651233B1 (fr) * 1989-08-23 1991-12-13 Roussel Uclaf Nouveaux acides omega-phenylamino alcanouiques substitues sur le noyau aromatique par un radical derive de 19-norsterouides, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant.
FR2654337B1 (fr) * 1989-11-15 1994-08-05 Roussel Uclaf Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
DE4018168A1 (de) * 1990-06-01 1991-12-05 Schering Ag Ausgangsverbindungen fuer die herstellung von 10ss-h-steroiden und ein verfahren zur herstellung dieser ausgangsverbindungen
ZA929315B (en) * 1991-12-20 1993-05-24 Akzo Nv 17-spirofuran-3'-ylidene steroids.
CA2100514C (en) * 1992-07-29 2005-03-29 Johannes A. M. Hamersma 17-spiromethylene steroids
FR2757399B1 (fr) * 1996-12-23 1999-12-17 Hoechst Marion Roussel Inc Application de composes steroides substitues en 11 pour la fabrication de medicaments ayant une activite estrogene dissociee
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
ATE473759T1 (de) 1998-05-22 2010-07-15 Univ Leland Stanford Junior Bifunktionelle moleküle sowie darauf basierende therapien.
US6262042B1 (en) 1998-05-29 2001-07-17 Research Triangle Institute 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US5962444A (en) * 1998-05-29 1999-10-05 Research Triangle Institute 17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
FR2789393B1 (fr) * 1999-02-05 2001-10-12 Centre Nat Rech Scient Lactol steroidique
CN103259027A (zh) 2005-04-28 2013-08-21 普罗透斯数字保健公司 药物信息系统
JP2009508494A (ja) 2005-09-16 2009-03-05 ラプトール ファーマシューティカル インコーポレイテッド Ｃｒを含むタンパク質に対して特異的な受容体−結合タンパク質（ｒａｐ）変異体を含む組成物およびその使用
DE102006054535A1 (de) * 2006-11-15 2008-05-21 Bayer Schering Pharma Aktiengesellschaft Progesteronrezeptorantagonisten
GB0711948D0 (en) * 2007-06-20 2007-08-01 Bionature E A Ltd Neurosteriod compounds
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
TWI556839B (zh) 2009-05-06 2016-11-11 研究室護膚股份有限公司 包含活性劑－磷酸鈣粒子複合物之皮膚遞送組成物及其使用方法
DE102009034362A1 (de) * 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034367A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034368A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034366A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) * 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
IN2012DN02613A (ja) * 2009-09-11 2015-09-04 Bionature E A Ltd
DE102010007719A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
US9096641B2 (en) * 2013-06-05 2015-08-04 Evestra, Inc. Imidazolyl progesterone antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3509135A (en) * 1968-07-26 1970-04-28 Searle & Co 3-oxygenated 4'-5 - dihydrospiro(estra-4,9-diene-17,2'(3'h)-furans) and congeners
US3764596A (en) * 1971-06-22 1973-10-09 Sandoz Ag 17-dihydrofuranyl-substituted steroids
FR2496669A1 (fr) * 1980-12-23 1982-06-25 Roussel Uclaf Nouveaux derives steroides 3-ceto4 ou1-4 substitues en position 7, leur procede de preparation et leur application comme medicaments
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
DE3410880A1 (de) * 1984-03-21 1985-10-03 Schering AG, Berlin und Bergkamen, 1000 Berlin 17-substituierte estradiene und estratriene

Also Published As

Publication number Publication date
YU53387A (en) 1988-08-31
KR880701244A (ko) 1988-07-26
JP2684180B2 (ja) 1997-12-03
DK174211B1 (da) 2002-09-23
ZA872130B (en) 1988-05-25
IL82004A0 (en) 1987-10-20
HU198509B (en) 1989-10-30
CA1299169C (fr) 1992-04-21
US4900725A (en) 1990-02-13
FR2596395B1 (fr) 1989-05-26
EP0262188B1 (fr) 1990-11-14
PT84554A (fr) 1987-04-01
JPS63502902A (ja) 1988-10-27
WO1987005908A1 (fr) 1987-10-08
GR870471B (en) 1987-07-30
OA08505A (fr) 1988-07-29
NZ219776A (en) 1990-03-27
CN1021445C (zh) 1993-06-30
FI875202A (fi) 1987-11-25
MX5712A (es) 1993-11-01
FI875202A0 (fi) 1987-11-25
CN87103193A (zh) 1988-01-13
ES2004268A6 (es) 1988-12-16
DK618287A (da) 1988-01-22
AU604692B2 (en) 1991-01-03
FR2596395A1 (fr) 1987-10-02
SU1715205A3 (ru) 1992-02-23
JP2652007B2 (ja) 1997-09-10
AU7167487A (en) 1987-10-20
IE60143B1 (en) 1994-06-01
HUT46037A (en) 1988-09-28
TR23117A (tr) 1989-04-03
IE870772L (en) 1987-09-26
JPH08311094A (ja) 1996-11-26
DK618287D0 (da) 1987-11-25
PT84554B (pt) 1989-11-10
FI87078C (fi) 1992-11-25
TNSN87042A1 (fr) 1990-01-01
EP0262188A1 (fr) 1988-04-06
FI87078B (fi) 1992-08-14
MA20918A1 (fr) 1987-10-01

Similar Documents

Publication Publication Date Title
PH25612A (en) Steroids including a spiro-ring in position 17, the process for their preparation, their use
PT85239A (en) Process for the preparation of-aryl-phenyl-ethyl-1h-1,2,4-triazole-1-propanenitriles
EP0260938A3 (en) Erythromycin a derivatives and method for preparing the same
IL86027A0 (en) New 2-acylpyrrolidine derivatives,a process for the preparation thereof,agents containing them,and their use
ZA856431B (en) 1,6-naphthyridine derivatives,process for the preparation and the use thereof
ZA879330B (en) Substituted aminopropionamides,a process for their preparation,agents containing them,and their use,and new intermediates produced in the preparation
HUT42136A (en) Process for preparing 4-androsten-3,17-dione 1,4-androstadien-3,17-dione
IL65387A0 (en) 2,3,4-trinor-m-inter-phenylene-prostaglandin derivatives and a process for the preparation thereof
ZA871756B (en) Arylazolylmethylbenzocycloalkene derivatives,processes for the preparation thereof,and the use thereof
GB2051054B (en) Pyrazolo (1,5-c) quinazoline derivatives and a process for the preparation thereof
IL63061A0 (en) 6-hydrazino-pyrido(2,1,b)quinazoline-11-ones,and a process for the preparation thereo
IL84987A0 (en) Nitrohaloalkoxybenzenes,a process for their preparation,and their use
EP0115811A3 (en) 2,4-dichlor-5-thiazolecarboxaldehyd and a process for its preparation
GB2199827B (en) Novel aminoalkanoyl-dibenzo[d,g][1,3,6]dioxazocines and a process for the preparation thereof
EP0237004A3 (en) A crystalline aromatic polyketone copolymer and a process for producing the same
FI103795B1 (fi) 19,11beta-sillan käsittäviä steroideja
GB2158072B (en) 23,23-difluoro steroids
IL63159A0 (en) Indolo(2,3,4)pyrido(2,1,b)quin-azoline-5-ones and a process for the preparation thereof
GB2051792B (en) Pyrido (3,2 - e) - as - triazine derivatives and a process for the preparation thereof
ZA849153B (en) A novel lactone derivative,process for the preparation thereof,and use thereof in pest control
ZA861372B (en) 1,6-naphthyridine derivatives,process for the preparation and the use thereof
ZA887564B (en) New anthracycline derivatives,a process for the preparation thereof,and the use thereof as pharmaceuticals
IE873370L (en) Substituted aminopropionamides, a process for their¹preparation, agents containing them, and their use, and new¹intermediates produced in the preparation
ZA836055B (en) New 14-amino steroid derivatives,a process for the preparation thereof and use thereof in therapy
CS857386A1 (en) Etylen vinylacetatovy kopolymer obsahujuci 2,2,6,6 tetrametyl 4 piperidylamino skupiny a sposob jeho pripravy